Eiger BioPharmaceuticals (EIGR) Stock Chart & Stock Price History → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free EIGR Stock Alerts Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Eiger BioPharmaceuticals Stock Price Performance5 Day Performance-100.00%1 Month Performance-100.00%3 Month Performance-100.00%6 Month Performance-100.00%Year-To-Date Performance-100.00%1 Year Performance-100.00% Receive EIGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). EIGR Stock Chart for Friday, April, 26, 2024 EIGR Chart by TradingView Eiger BioPharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$1.73$1.73$1.90$1.66137,800 shs$2.55 million04/22/2024N/A$1.73$1.90$1.66137,800 shs$2.55 million04/16/2024$1.73$1.73$1.90$1.66137,800 shs$2.55 million04/15/2024N/A$1.73$1.90$1.66137,800 shs$2.55 million04/10/2024$1.90$1.73-9.21%$1.90$1.66130,212 shs$2.55 million04/09/2024$2.11$1.90-9.95%$2.10$1.88117,787 shs$2.81 million Get the Latest News and Ratings for EIGR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/08/2024$2.30$2.11-8.26%$2.24$2.00128,847 shs$3.12 million04/05/2024$2.26$2.30+1.77%$2.60$1.86310,338 shs$3.40 million04/04/2024$1.65$2.26+36.97%$2.83$1.751.30 million shs$3.35 million04/03/2024$1.30$1.65+26.92%$2.65$1.252.93 million shs$2.44 million04/02/2024$1.39$1.30-6.47%$1.41$1.13558,608 shs$1.92 million04/01/2024$5.01$1.39-72.23%$5.24$1.10967,317 shs$2.06 million03/29/2024$5.00$5.01+0.10%$5.16$5.003,982 shs$7.41 million03/28/2024$4.97$5.00+0.60%$5.14$5.003,982 shs$7.40 million03/27/2024$5.40$4.97-7.96%$5.37$4.854,748 shs$7.36 million03/26/2024$5.59$5.40-3.40%$5.45$4.7920,165 shs$7.99 million03/25/2024$5.76$5.59-2.95%$6.15$5.447,529 shs$8.27 million03/22/2024$5.96$5.76-3.36%$6.08$5.4213,265 shs$8.53 million03/21/2024$5.37$5.96+10.99%$6.77$5.6623,977 shs$8.82 million03/20/2024$4.81$5.37+11.64%$7.20$5.13154,516 shs$7.95 million03/19/2024$5.11$4.81-5.87%$5.39$4.8112,199 shs$7.12 million03/18/2024$5.14$5.11-0.58%$5.45$5.1115,181 shs$7.56 million03/15/2024$5.33$5.14-3.56%$5.63$5.1416,368 shs$7.61 million03/14/2024$6.00$5.33-11.17%$6.30$5.2815,231 shs$7.89 million03/13/2024$5.90$6.00+1.69%$6.60$5.958,528 shs$8.88 million03/12/2024$6.75$5.90-12.59%$6.92$5.9012,578 shs$8.73 million03/11/2024$6.91$6.75-2.38%$7.26$6.643,367 shs$9.99 million03/08/2024$7.17$6.92-3.42%$7.35$6.915,336 shs$10.24 million03/07/2024$6.80$7.17+5.37%$7.18$6.565,240 shs$10.60 million03/06/2024$6.95$6.80-2.16%$7.36$6.616,002 shs$10.06 million03/05/2024$6.29$6.95+10.49%$7.50$6.4216,306 shs$10.29 million03/04/2024$7.00$6.29-10.14%$8.27$6.2019,797 shs$9.31 million03/01/2024$5.60$7.00+25.00%$8.00$5.9039,393 shs$10.36 million02/29/2024$5.80$5.60-3.45%$6.23$5.602,598 shs$8.29 million02/28/2024$5.80$5.80$5.97$5.723,107 shs$8.58 million02/27/2024$5.80$5.80+0.00%$6.40$5.804,515 shs$8.58 million02/26/2024$5.41$5.80+7.21%$5.80$5.535,115 shs$8.57 million02/23/2024$5.60$5.41-3.39%$5.76$5.1211,986 shs$8.01 million02/22/2024$5.80$5.60-3.45%$5.80$5.601,708 shs$8.29 million02/21/2024$5.65$5.80+2.65%$5.98$5.653,475 shs$8.58 million“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).02/20/2024$5.73$5.65-1.40%$5.74$5.562,946 shs$8.36 million02/19/2024$5.73$5.73$6.06$5.682,700 shs$8.48 million02/16/2024$5.68$5.73+0.88%$6.06$5.682,774 shs$8.48 million02/15/2024$5.80$5.68-2.07%$6.07$5.682,818 shs$8.41 million02/14/2024$5.82$5.80-0.34%$5.82$5.802,179 shs$8.58 million02/13/2024$5.81$5.82+0.17%$5.82$5.706,857 shs$8.61 million02/12/2024$5.76$5.81+0.87%$6.23$5.7617,909 shs$8.60 million02/09/2024$5.96$5.80-2.68%$6.14$5.768,961 shs$8.58 million02/08/2024$5.99$5.96-0.50%$6.25$5.886,908 shs$8.82 million02/07/2024$6.39$5.99-6.26%$6.40$5.992,992 shs$8.87 million02/06/2024$6.52$6.39-1.99%$6.62$6.333,235 shs$9.46 million02/05/2024$6.51$6.52+0.15%$6.77$6.503,986 shs$9.65 million02/02/2024$6.55$6.51-0.61%$6.90$6.509,564 shs$9.62 million02/01/2024$6.51$6.55+0.61%$7.18$6.2511,280 shs$9.69 million01/31/2024$6.11$6.51+6.55%$6.93$6.118,983 shs$9.64 million01/30/2024$6.00$6.11+1.83%$6.11$6.004,413 shs$9.04 million01/29/2024$5.88$6.00+2.04%$6.11$5.813,699 shs$8.88 million01/26/2024$5.86$5.88+0.34%$6.16$5.757,121 shs$8.70 million01/25/2024$6.11$5.86-4.09%$6.05$5.754,785 shs$8.67 million Related Companies: 9 Meters Biopharma Stock Chart Pulmatrix Stock Chart Gamida Cell Stock Chart Eloxx Pharmaceuticals Stock Chart Altamira Therapeutics Stock Chart CohBar Stock Chart Sonoma Pharmaceuticals Stock Chart Dynatronics Stock Chart Quoin Pharmaceuticals Stock Chart Tenon Medical Stock Chart Receive EIGR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EIGR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eiger BioPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.